↓ Skip to main content

A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment…

Overview of attention for article published in Trials, April 2014
Altmetric Badge

Mentioned by

twitter
6 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
74 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study
Published in
Trials, April 2014
DOI 10.1186/1745-6215-15-122
Pubmed ID
Authors

Joanna D Smith, Jessica Baillie, Trevor Baglin, Gareth O Griffiths, Angela Casbard, David Cohen, David A Fitzmaurice, Kerenza Hood, Peter Rose, Alexander T Cohen, Miriam Johnson, Anthony Maraveyas, John Bell, Harold Toone, Annmarie Nelson, Simon I Noble

Abstract

Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastatic cancer. This recommendation, based on expert consensus, has not been evaluated in a clinical study. ALICAT (Anticoagulation Length in Cancer Associated Thrombosis) is a feasibility study to identify the most clinically and cost effective length of anticoagulation with low molecular weight heparin in the treatment of cancer associated thrombosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Denmark 1 1%
Egypt 1 1%
Unknown 71 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Student > Bachelor 11 15%
Researcher 10 14%
Other 6 8%
Student > Postgraduate 6 8%
Other 10 14%
Unknown 18 24%
Readers by discipline Count As %
Medicine and Dentistry 25 34%
Nursing and Health Professions 11 15%
Psychology 4 5%
Sports and Recreations 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 7 9%
Unknown 22 30%